Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
Your gut has been called your "second brain," and emerging research suggests it might hold the key to understanding anxiety disorders. Recent studies have revealed an intricate communication network between the gut and brain called the microbiome-gut-brain axis, offering new hope for the estimated 264 million people worldwide who suffer from anxiety.
More than 90% of the body's serotonin and 50% of dopamine – neurotransmitters crucial for mood regulation – are produced in the gut. Johns Hopkins Medicine explains that hidden in the digestive system walls is an enteric nervous system (ENS) containing over 100 million nerve cells that revolutionizes our understanding of the links between digestion and mental health.
A comprehensive 2025 study published in MDPI identified specific bacterial signatures associated with anxiety disorders. Chinese scientists led by Jianbing Li found nine bacterial traits significantly linked to anxiety risk. Four bacteria, including Blautia and Butyricicoccus, showed protective effects against anxiety, while five others, including Eubacterium brachy and Coprococcus, increased anxiety risk.
This builds on UCLA research finding distinct microbiome signatures in stress-resilient individuals. Lead researcher Arpana Church noted that "the accuracy with which these patterns emerged was really amazing."
The gut-brain communication involves multiple pathways. According to PMC research, gut bacteria produce neurotransmitters like GABA, serotonin, and dopamine that directly influence brain function. Additionally, gut microbes produce short-chain fatty acids (SCFAs) from fiber digestion that can cross the blood-brain barrier and affect mood regulation.
Breakthrough clinical trials testing "psychobiotics" have yielded remarkable results. A 2024 comprehensive review of trials from 2014-2023 found compelling evidence for probiotic effectiveness in treating anxiety and depression, with Lactobacillus and Bifidobacterium showing the strongest benefits.
Most impressively, a clinical trial found that Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduced anxiety and depression scores by 50% in healthy individuals without side effects.
Recent network meta-analysis involving 4,053 participants across 45 trials revealed that Bifidobacterium was optimal for improving anxiety symptoms, followed by Lactobacillus.
Research suggests inflammation is a key mechanism. Nearly half of probiotic studies showed decreased inflammation markers. Since neuroinflammation contributes to anxiety and depression pathophysiology, probiotic benefits may stem from reducing inflammatory cytokines like IL-6.
Jane Foster, a neuroscientist at UT Southwestern Medical Center, found that bacteria producing short-chain fatty acids were reduced in people with depression and elevated anxiety. Regarding stress resilience research in general, scientists have found that changing the composition of the microbiome could make some mice more resilient to stress.
Also see: How expressing gratitude can transform your work and life
